African Journal of Pharmaceutical Sciences
|
Volume 2, Issue 1, March 2022 | |
Case ReportOpenAccess | |
Henoch-Schonlein Purpura with TCM Trials – A Case Report |
|
George Zhu1* |
|
1University Hospital Leiden, Netherlands. E-mail: zhu13574916119@163.com
*Corresponding Author | |
Afr. J. Pharm. Sci. 2(1) (2022) 1-3, DOI: https://doi.org/10.51483/AFJPS.2.1.2022.1-3 | |
Received: 29/10/2021|Accepted: 19/02/2022|Published: 01/03/2022 |
Henoch-Schonlein Purpura (HSP), also known as “anaphylactoid purpura”, is a systemic vasculitis of unknown cause, primarily affecting children, in which circulating immune complexes of IgA and C3 are deposited on arteioles, capillaries and venules. It is characterized by nonthrombocytopenic purpuric rash, abdominal pain, arthralgia and renal involvement. Here, this report presented a 13-year old children hospitalized for his recurrent HSP, his history of clinical course and treatment outcome.
Keywords: Henoch-Schonlein purpura, Corticosteroid, Traditional Medicine (TCM), Children
Full text | Download |
Copyright © SvedbergOpen. All rights reserved